MicroRNA‑654‑3p enhances cisplatin sensitivity by targeting QPRT and inhibiting the PI3K/AKT signaling pathway in ovarian cancer cells

Yichao Niu(Shanghai First Maternity and Infant Hospital), Ting Zhang(Jilin University)
Experimental and Therapeutic Medicine
June 11, 2020
Cited by 26


Related Papers